Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
1,457,592
Value
$132.3M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,457,592$132.3M0.1%−3,822,462−72.4%ReducedHolders
Q1 20265,280,054$542.1M0.4%+3,926,863+290.2%AddedHolders
Q4 20251,353,191$169.5M0.1%+1,313,349+3,296.4%AddedHolders
Q3 202539,842$5.34M<0.1%+33,563+534.5%AddedHolders
Q2 20256,279$854.0K<0.1%−10,851−63.3%ReducedHolders
Q1 202517,130$2.27M<0.1%−11,926−41.0%ReducedHolders
Q4 202429,056$3.29M<0.1%−67,423−69.9%ReducedHolders
Q3 202496,479$11.0M<0.1%−922,405−90.5%ReducedHolders
Q2 20241,018,884$105.9M0.1%+967,955+1,900.6%AddedHolders
Q1 202450,929$5.79M<0.1%+41,074+416.8%AddedHolders
Q4 20239,855$1.08M<0.1%−130,858−93.0%ReducedHolders
Q3 2023140,713$13.6M<0.1%−328,432−70.0%ReducedHolders
Q2 2023469,145$51.1M0.1%−309,648−39.8%ReducedHolders
Q1 2023778,793$78.9M0.1%+323,492+71.1%AddedHolders
Q4 2022455,301$50.0M0.1%−825,754−64.5%ReducedHolders
Q3 20221,281,055$124.0M0.2%−346,803−21.3%ReducedHolders
Q2 20221,627,858$176.9M0.3%−726,020−30.8%ReducedHolders
Q1 20222,353,878$278.6M0.4%+1,757,136+294.5%AddedHolders
Q4 2021596,742$84.0M0.1%−107,350−15.2%ReducedHolders
Q3 2021704,092$83.2M0.1%−1,486,607−67.9%ReducedHolders
Q2 20212,190,699$254.0M0.3%+463,759+26.9%AddedHolders
Q1 20211,726,940$207.0M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.